KMTS Key Statistics, Chart & Performance
The current stock price of KMTS is 24.43 USD. In the past month the price decreased by -0.37%.
KMTS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.23 | 218.96B | ||
| ISRG | INTUITIVE SURGICAL INC | 68.09 | 207.82B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.1 | 144.75B | ||
| SYK | STRYKER CORP | 27.91 | 140.55B | ||
| BDX | BECTON DICKINSON AND CO | 14.06 | 57.87B | ||
| IDXX | IDEXX LABORATORIES INC | 56.57 | 56.96B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.12 | 49.40B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 19.02 | 39.76B | ||
| RMD | RESMED INC | 25.5 | 36.85B | ||
| DXCM | DEXCOM INC | 36.24 | 26.29B | ||
| PODD | INSULET CORP | 63.25 | 20.33B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.48 | 18.40B |
Related stock screener links
About KMTS
Company Profile
Kestra Medical Technologies Ltd. is a commercial-stage, wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington and currently employs 330 full-time employees. The company went IPO on 2025-03-06. The firm has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The firm's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.
Company Info
KESTRA MEDICAL TECHNOLOGIES
3933 Lake Washington Blvd Ne, Suite 200
Kirkland WASHINGTON US
Employees: 330
Phone: 14252798002
KESTRA MEDICAL TECHNOLOGIES / KMTS FAQ
What does KESTRA MEDICAL TECHNOLOGIES do?
Kestra Medical Technologies Ltd. is a commercial-stage, wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington and currently employs 330 full-time employees. The company went IPO on 2025-03-06. The firm has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The firm's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.
What is the stock price of KESTRA MEDICAL TECHNOLOGIES today?
The current stock price of KMTS is 24.43 USD. The price decreased by -8.33% in the last trading session.
Does KMTS stock pay dividends?
KMTS does not pay a dividend.
How is the ChartMill rating for KESTRA MEDICAL TECHNOLOGIES?
KMTS has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the market capitalization of KMTS stock?
KESTRA MEDICAL TECHNOLOGIES (KMTS) has a market capitalization of 1.40B USD. This makes KMTS a Small Cap stock.
What is the outstanding short interest for KESTRA MEDICAL TECHNOLOGIES?
The outstanding short interest for KESTRA MEDICAL TECHNOLOGIES (KMTS) is 7.33% of its float.
KMTS Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to KMTS.
KMTS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to KMTS. While KMTS seems to be doing ok healthwise, there are quite some concerns on its profitability.
KMTS Financial Highlights
Over the last trailing twelve months KMTS reported a non-GAAP Earnings per Share(EPS) of -2.76. The EPS decreased by -46.2% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -56.26% | ||
| ROE | -84.59% | ||
| Debt/Equity | 0.26 |
KMTS Forecast & Estimates
13 analysts have analysed KMTS and the average price target is 29.73 USD. This implies a price increase of 21.68% is expected in the next year compared to the current price of 24.43.
For the next year, analysts expect an EPS growth of -5.05% and a revenue growth 56.29% for KMTS